Tuberculosis (TB) is one of the world’s biggest global health crises. Killing 1.5 million people in 2020, TB is the world’s second deadliest infectious disease after COVID-19 (WHO).

Obsolete treatments, the lack of an effective vaccine, and the lack of suitable diagnostic tools make it difficult to control the global TB epidemic.

Some gains have been made in recent years; the first new TB drugs in half a century and the trial of a shorter course of treatment for drug-resistant TB (DR-TB). But the harsh reality remains - 10 million people fell sick with TB in 2020 and nearly half a million developed DR-TB, which is much harder to treat. Only about one-third of people with DR-TB accessed treatment in 2020. The majority go undiagnosed and therefore untreated.

IN 2021

Quick facts about Tuberculosis

MSF, Doctors Without Borders, India rejects Johnson & Johnson patent extension attempt
Drug-resistant TB

MSF applauds Indian Patent Office’s rejection of Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug

Press Release 23 Mar 2023

How do you deal with a disease as old as the pharaohs? Try teaching TB at schools, says MSF

Latest News 20 Mar 2023
MSF nurses provides HIV Counselling, Testing and Treatment to a farm worker in Eshowe, KwaZulu-Natal

Patient Support, Education and Counselling Guideline

MSF medical resource 21 Feb 2023
A doctor consults a patient in Michael Mapongwane Community Health Centre’s HIV/TB unit in Khayelitsha, Western Cape, where MSF works alongside the health ministry to provide a range of integrated HIV TB services.

MSF HIV/TB Clinical Guide for Primary Care

MSF medical resource 3 Feb 2023
MSF staff at the tuberculosis ward in Homa Bay. Kenya

MSF HIV/TB Guide: Hospital Level

MSF medical resource 3 Feb 2023
MSF Pharmacist dispensing Bedaquiline and Delamanid based DRTB
Multi-drug Resistant Tuberculosis

TB-PRACTECAL: Groundbreaking MSF trial finds better treatment for people with drug-resistant tuberculosis

Press Release 21 Dec 2022